Planning Grant for TOPS for Breast Cancer Survivors
Planning Grant for Take Off Pounds Sensibly (TOPS) Classes for Breast Cancer Survivors
1 other identifier
interventional
25
1 country
1
Brief Summary
The purpose of this study is to help make a community led weight loss program known as Take Off Pounds Sensibly (TOPS) more relevant for breast cancer survivors. This study is made up to two parts. The first part includes using focus groups to review current materials that the investigators plan to use in upcoming TOPS classes and provide feedback. Focus groups will be made up of women who are breast cancer survivors. The second part includes taking the feedback received from these focus groups and use this feedback to tailor TOPS classes for breast cancer survivors. This ClinicalTrials.gov record is specific to the second part of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable breast-cancer
Started Jun 2026
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2024
CompletedFirst Posted
Study publicly available on registry
October 26, 2024
CompletedStudy Start
First participant enrolled
June 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2027
Study Completion
Last participant's last visit for all outcomes
September 30, 2027
April 8, 2026
April 1, 2026
1.3 years
October 23, 2024
April 7, 2026
Conditions
Outcome Measures
Primary Outcomes (6)
Number of invitations sent through the electronic health record to get 25 individuals consented to the study
1-2 months
Percentage of TOPS group session attendance
This will be calculated as number of sessions attended divided by total number of sessions offered
12 months
Number of participants who stay in the study
3 months, 6 months, 9 months, 12 months
Number of participants who transition from the initiation phase to the maintenance phase
12 months
Number of participants who continue to transmit weight and BP data once they transition to the maintenance phase
9 months, 12 months
Percent of Weight Loss
Up to 12 Months
Secondary Outcomes (5)
Cardiovascular Disease (CVD) risk factors as measured by blood pressure
up to 12 months
Cardiovascular Disease (CVD) risk factors as measured by hemoglobin A1c
up to 12 months
Cardiovascular Disease (CVD) risk factors as measured by glucose
up to 12 months
Percentage of participants who get blood drawn
Baseline, 3 months, 6 months,12 months
Quality of Life (QOL) as measured by survey
up to 12 months
Study Arms (1)
TOPS Classes
OTHERInterventions
Eligibility Criteria
You may qualify if:
- women diagnosed with breast cancer with BMI ≥ 25 kg/m2 after completion of primary therapy (surgery, radiation, adjuvant or neo-adjuvant chemotherapy).
You may not qualify if:
- Those whose oncology providers do not agree with their participation in a weight loss program
- History of Type II Diabetes Mellitus
- those participating in another weight loss program
- those taking a weight loss medication
- those without smart phones or internet connections or the ability to attend meetings via Zoom
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nia S Mitchell, MD
Duke University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2024
First Posted
October 26, 2024
Study Start (Estimated)
June 1, 2026
Primary Completion (Estimated)
September 30, 2027
Study Completion (Estimated)
September 30, 2027
Last Updated
April 8, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share